Warfarin is the second-most-likely drug, to cause adverse events requiring hospitalization. The use of warfarin sensitivity testing in the U.S. could avoid 85,000 serious-bleeding incidents. More in the way of personalized medicine and if you were a patient determined to have an adverse reaction to the drug, this perhaps could be lifesaving to make sure a wrong dose is not delivered or perhaps if it should be used. BD
“ NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for arketing Osmetech’s eSensor Warfarin Sensitivity Test, the London-based firm announced today.
The genetic test is used to aid physicians in identifying patients who are at risk for increased sensitivity to the blood-thinning drug warfarin. Osmetech submitted its application with the FDA for the test at the beginning of this year. The firm said that the FDA also cleared its second-generation eSensor XT-8 molecular diagnostics platform.”